Venous Thromboembolism News and Research RSS Feed - Venous Thromboembolism News and Research

Genetic susceptibility could help identify breast cancer patients at risk of developing VTE

Genetic susceptibility could help identify breast cancer patients at risk of developing VTE

Genetic testing could help identify breast cancer patients with high risk of experiencing venous thromboembolism (VTE), a serious and potentially fatal complication that can occur during cancer treatment. [More]
Increasing trends in maternal obesity could impact mother and child

Increasing trends in maternal obesity could impact mother and child

The epidemic of obesity is felt in prenatal clinics and delivery rooms around the world with a worrisome trend in high-risk pregnancies that could impact mother and child, according to Patrick M. Catalano, MD, the Dierker-Biscotti Women's Health and Wellness Professor and Director of the Center for Reproductive Health at MetroHealth and Director of the Clinical Research Unit of the Case Western Reserve University. [More]
Cesarean-section leaves women more vulnerable to VTE than vaginal delivery

Cesarean-section leaves women more vulnerable to VTE than vaginal delivery

Roughly one-third of all births in Europe and North America now occur via cesarean section (CS). Following any birth, women are at an increased risk for a venous thromboembolism (VTE), but it's believed that CS leaves women more vulnerable to VTE, blood clots, than vaginal delivery (VD). [More]
Simple diagnostic algorithm to assess pulmonary embolism risk can help reduce rate of CTPA imaging

Simple diagnostic algorithm to assess pulmonary embolism risk can help reduce rate of CTPA imaging

Patients with suspected pulmonary embolism (PE) often undergo computed tomography pulmonary angiography (CTPA) to confirm or exclude the diagnosis. [More]
REVERSE II trial validates HERDOO2 rule to help spot women who can discontinue anticoagulants

REVERSE II trial validates HERDOO2 rule to help spot women who can discontinue anticoagulants

A clinical decision rule (CDR) that can be applied to women after a first, unprovoked venous thromboembolism (VTE) was able to identify those with a low-risk of recurrence who could safely discontinue anticoagulant therapy, researchers reported at ESC Congress 2016. [More]
Early initiation of prophylaxis linked to lower rates of PE and DVT in patients with severe brain injuries

Early initiation of prophylaxis linked to lower rates of PE and DVT in patients with severe brain injuries

People who sustain a traumatic brain injury (TBI) are at high risk for developing deep vein thrombosis (DVT) and pulmonary embolism (PE). PE is a leading cause of death in these patients. [More]
UNC professor identifies research priorities to address VTE in cancer patients

UNC professor identifies research priorities to address VTE in cancer patients

More than 20 percent of all blood clots in veins occur in cancer patients. These clots, also known as venous thromboembolism (VTE), pose serious threats for cancer patients. [More]
iMDsoft launches new mobile e-obs solution for early detection of sepsis and AKI

iMDsoft launches new mobile e-obs solution for early detection of sepsis and AKI

iMDsoft announced that they will be featuring new and advanced tools for detecting patient deterioration at Patient Safety Congress in Manchester, 5 - 6 July 2016. [More]
NOACs match warfarin for atrial fibrillation

NOACs match warfarin for atrial fibrillation

Real-world study data from Denmark show that non-vitamin K antagonist oral anticoagulants are effective alternatives to warfarin in patients with non-valvular atrial fibrillation in a routine care setting. [More]
Betrixaban scores near miss for extended thromboprophylaxis

Betrixaban scores near miss for extended thromboprophylaxis

Extended thromboprophylaxis with the direct factor Xa inhibitor betrixaban just fails to show superiority to standard treatment with enoxaparin in acutely ill medical patients. [More]
Swedish population study helps answer lingering questions about hormone therapy safety

Swedish population study helps answer lingering questions about hormone therapy safety

A Swedish population study is helping answer lingering questions about hormone therapy safety. Published online today in Menopause, the journal of The North American Menopause Society, the study shows that estrogen-only therapy carries a lower risk of blood clots than combined estrogen-progestogen therapy, but there is no significantly increased risk of clots with combination therapy when the estrogen is transdermal, and vaginal estrogen doesn't raise the risk at all. [More]
Oral contraceptives increase rare stroke risk in obese women

Oral contraceptives increase rare stroke risk in obese women

Researchers have found that obese women taking oral contraceptives have an increased risk of cerebral venous thrombosis and should be educated about this risk accordingly. [More]
VTE patients tend to die earlier from bladder cancer

VTE patients tend to die earlier from bladder cancer

In a study of 3879 patients who underwent radical cystectomy to treat bladder cancer, 3.6% were diagnosed with a venous thromboembolism (VTE)—which occurs when a blood clot forms in a vein, potentially breaking loose and traveling to the lung—within 1 month of their surgical admission date. [More]
African Americans with common genetic variants at increased risk for blood clots

African Americans with common genetic variants at increased risk for blood clots

New research published online today in Blood, the Journal of the American Society of Hematology (ASH), identifies common genetic variants predominantly found in African Americans that double their risk for blood clots. [More]
Researchers find association between obesity and VTE in pediatric populations

Researchers find association between obesity and VTE in pediatric populations

Researchers at Wake Forest Baptist Medical Center have found an association between obesity and the formation of blood clots in the veins of children and adolescents. [More]
New perioperative guideline released for optimal management of geriatric patients

New perioperative guideline released for optimal management of geriatric patients

Responding to the needs of the country's growing older adult population, a new collaborative best practices guideline was released today for optimal care of older adults immediately before, during, and after surgical operations (a timeframe known as the "perioperative" period). [More]
Study: Preoperative use of blood-thinning drugs associated with decreased risk of blood clots

Study: Preoperative use of blood-thinning drugs associated with decreased risk of blood clots

Among patients undergoing major cancer operations, the preoperative use of blood-thinning drugs such as heparin does not increase rates of major bleeding or transfusions, and is associated with a decreased risk of blood clots, according to new study results published online in the Journal of the American College of Surgeons ahead of print publication early next year. [More]
Providing novice surgeons with regular feedback can help prevent blood clots among hospitalized patients

Providing novice surgeons with regular feedback can help prevent blood clots among hospitalized patients

A study of general surgery residents at The Johns Hopkins Hospital suggests that in the efforts to prevent dangerous blood clots among hospitalized patients, regular, one-on-one feedback and written report cards work a lot better than the usual group lectures that newly minted surgeons receive as part of their training. [More]
XARELTO reduces rates of major bleeding, recurrent blood clots in people with deep vein thrombosis

XARELTO reduces rates of major bleeding, recurrent blood clots in people with deep vein thrombosis

Janssen Pharmaceuticals, Inc. and its development partner, Bayer HealthCare, today announced the results from their real-world study XALIA showing that, in people with deep vein thrombosis (DVT), the rates of major bleeding and recurrent blood clots for XARELTO (rivaroxaban) in routine clinical practice were generally consistent with those observed in Phase 3 research. [More]
Boston Scientific obtains FDA approval, CE Mark for AngioJet ZelanteDVT catheter to treat DVT

Boston Scientific obtains FDA approval, CE Mark for AngioJet ZelanteDVT catheter to treat DVT

Boston Scientific has received United States (U.S.) Food and Drug Administration approval and CE Mark for the AngioJet ZelanteDVT thrombectomy catheter to treat deep vein thrombosis (DVT) in large-diameter upper and lower limb peripheral veins. [More]